Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Zeynep Dönmez, Ahmet Akçay, Ummuhan Ebru Karabulut, Bahar Atasoy, Abdüsselim Adil Peker, Hüseyin Toprak, Mehmet Ali Gültekin
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2021
Cancer statistics, 2024
2024
NCCN Guidelines insights: ovarian cancer, version 3.2022
10.6004/jnccn.2022.0047 · 2022
Ovarian cancer: epidemiology, biology, and prognostic factors
10.1002/1098-2388(200007/08)19:1<3::aid-ssu2>3.0.co;2-s · 2000
Diagnosis and management of adnexal masses
2016
MR imaging for incidental adnexal mass characterization
10.1016/j.mric.2017.03.001 · 2017
Adnexal masses encountered during cesarean delivery
10.1016/j.ijgo.2013.06.015 · 2013
ACOG releases guidelines on management of adnexal masses
2008
Subjective assessment versus ultrasound models to diagnose ovarian cancer: a systematic review and meta-analysis
10.1016/j.ejca.2016.01.007 · 2016
Ovarian-adnexal reporting data system magnetic resonance imaging (O-RADS MRI) score for risk stratification of sonographically indeterminate adnexal masses
10.1001/jamanetworkopen.2019.19896 · 2020
O-RADS MRI risk stratification system: guide for assessing adnexal lesions from the ACR O-RADS committee
10.1148/radiol.204371 · 2022
O-RADS MRI score: analysis of misclassified cases in a prospective multicentric European cohort
10.1007/s00330-021-08054-x · 2021
O-RADS MRI scoring system: key points for correct application in inexperienced hands
10.1186/s13244-024-01670-3 · 2024
Diagnostic performance of the O-RADS MRI system for magnetic resonance imaging in discriminating benign and malignant adnexal lesions: a systematic review, meta-analysis, and meta-regression
2025
O-RADS MRI: a systematic review and meta-analysis of diagnostic performance and category-wise malignancy rates
10.1148/radiol.220795 · 2023
High agreement but low kappa: I. The problems of two paradoxes
10.1016/0895-4356(90)90158-l · 1990
Understanding interobserver agreement: the kappa statistic
2005
Bias, prevalence and kappa
10.1016/0895-4356(93)90018-v · 1993
Reliability, reproducibility, and potential pitfalls of the O-RADS scoring with non-dynamic MRI
10.1177/02841851241279897 · 2024
Accuracy and reproducibility of the O-RADS MRI risk stratification system based on enhanced non-DCE MRI in the assessment of adnexal masses
10.1016/j.ejrad.2022.110670 · 2023
Value of diffusion-weighted imaging combined with conventional magnetic resonance imaging in the diagnosis of thecomas/fibrothecomas and their differential diagnosis with malignant pelvic solid tumors
10.1186/s12957-015-0760-x · 2016
Magnetic resonance imaging features of ovarian fibroma, fibrothecoma, and thecoma
10.1007/s00261-014-0257-z · 2015
Polypoid endometriosis: a mimic of malignancy
10.1007/s00261-019-02143-8 · 2020
Pictorial essay: MRI evaluation of endometriosis-associated neoplasms
10.1186/s13244-023-01485-8 · 2023
Computed diffusion-weighted imaging for differentiating decidualized endometrioma from ovarian cancer
10.1016/j.ejrad.2016.03.009 · 2016
Fat-containing adnexal masses on MRI: solid tissue volume and fat distribution as a guide for O-RADS score assignment
10.1007/s00261-022-03688-x · 2023
Diagnostic utility of magnetic resonance imaging in discriminating immature teratoma: insights from a case series
10.1002/jcu.23715 · 2024
Role of magnetic resonance imaging in the differentiation of mucinous ovarian carcinoma and mucinous borderline ovarian tumors
10.1590/1806-9282.20230110 · 2023
Serous borderline ovarian tumours: an extensive review on MR imaging features
10.1259/bjr.20210116 · 2021
O-RADS MRI score: an essential first-step tool for the characterization of adnexal masses
10.1002/jmri.28947 · 2024
Role of magnetic resonance imaging to differentiate between borderline and malignant serous epithelial ovarian tumors
10.1007/s00261-023-04076-9 · 2024
Role of magnetic resonance imaging to differentiate between borderline and malignant serous epithelial ovarian tumors
10.1007/s00261-023-04076-9 · doi-reference
O-RADS MRI score: an essential first-step tool for the characterization of adnexal masses
10.1002/jmri.28947 · doi-reference
Serous borderline ovarian tumours: an extensive review on MR imaging features
10.1259/bjr.20210116 · doi-reference
Role of magnetic resonance imaging in the differentiation of mucinous ovarian carcinoma and mucinous borderline ovarian tumors
10.1590/1806-9282.20230110 · doi-reference
Diagnostic utility of magnetic resonance imaging in discriminating immature teratoma: insights from a case series
10.1002/jcu.23715 · doi-reference
Fat-containing adnexal masses on MRI: solid tissue volume and fat distribution as a guide for O-RADS score assignment
10.1007/s00261-022-03688-x · doi-reference
Computed diffusion-weighted imaging for differentiating decidualized endometrioma from ovarian cancer
10.1016/j.ejrad.2016.03.009 · doi-reference
Pictorial essay: MRI evaluation of endometriosis-associated neoplasms
10.1186/s13244-023-01485-8 · doi-reference
Polypoid endometriosis: a mimic of malignancy
10.1007/s00261-019-02143-8 · doi-reference
Magnetic resonance imaging features of ovarian fibroma, fibrothecoma, and thecoma
10.1007/s00261-014-0257-z · doi-reference
Value of diffusion-weighted imaging combined with conventional magnetic resonance imaging in the diagnosis of thecomas/fibrothecomas and their differential diagnosis with malignant pelvic solid tumors
10.1186/s12957-015-0760-x · doi-reference
Accuracy and reproducibility of the O-RADS MRI risk stratification system based on enhanced non-DCE MRI in the assessment of adnexal masses
10.1016/j.ejrad.2022.110670 · doi-reference
Reliability, reproducibility, and potential pitfalls of the O-RADS scoring with non-dynamic MRI
10.1177/02841851241279897 · doi-reference
Bias, prevalence and kappa
10.1016/0895-4356(93)90018-v · doi-reference
High agreement but low kappa: I. The problems of two paradoxes
10.1016/0895-4356(90)90158-l · doi-reference
O-RADS MRI: a systematic review and meta-analysis of diagnostic performance and category-wise malignancy rates
10.1148/radiol.220795 · doi-reference
O-RADS MRI scoring system: key points for correct application in inexperienced hands
10.1186/s13244-024-01670-3 · doi-reference
O-RADS MRI score: analysis of misclassified cases in a prospective multicentric European cohort
10.1007/s00330-021-08054-x · doi-reference
O-RADS MRI risk stratification system: guide for assessing adnexal lesions from the ACR O-RADS committee
10.1148/radiol.204371 · doi-reference
Ovarian-adnexal reporting data system magnetic resonance imaging (O-RADS MRI) score for risk stratification of sonographically indeterminate adnexal masses
10.1001/jamanetworkopen.2019.19896 · doi-reference
Subjective assessment versus ultrasound models to diagnose ovarian cancer: a systematic review and meta-analysis
10.1016/j.ejca.2016.01.007 · doi-reference
Adnexal masses encountered during cesarean delivery
10.1016/j.ijgo.2013.06.015 · doi-reference
MR imaging for incidental adnexal mass characterization
10.1016/j.mric.2017.03.001 · doi-reference
Ovarian cancer: epidemiology, biology, and prognostic factors
10.1002/1098-2388(200007/08)19:1<3::aid-ssu2>3.0.co;2-s · doi-reference
NCCN Guidelines insights: ovarian cancer, version 3.2022
10.6004/jnccn.2022.0047 · doi-reference